New HPV vaccines and fewer doses: promising recent developments towards eliminating cervical cancer (IARC Evidence Summary Brief No. 4)

The International Agency for Research on Cancer (IARC) has released a new IARC Evidence Summary Brief, titled “Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy”. This report highlights promising recent developments, led by scientists from IARC and partners, that are huge steps to accelerate the elimination of cervical cancer as a threat to global public health.

This IARC Evidence Summary Brief is the fourth in a series of scientific Evidence Summary Briefs published by IARC to call attention to the findings of evidence-based studies in key aspects of cancer prevention.

Read IARC Press Release 333

Read IARC Evidence Summary Brief No. 4

Read more about the IARC Evidence Summary Briefs series